Key facts
- NorthWest EHealth’s last known valuation is $19.1M (Jun 2021).
- It has raised $6.9M; the latest was PE Growth/Expansion ($260K) in Apr 2025.
- Notable investors include Christopher Cox, Clive Meanwell, Foresight Group, Population Health Partners, The University of Manchester.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for NorthWest EHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for NorthWest EHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NorthWest EHealth
Operator of a medical data collection company intended to use routine healthcare data for clinical trials. The company works with consenting patients who provide their data from primary care, secondary care, community pharmacies, and other data sources, thereby helping clients by delivering validated electronic health records (EHRs) and enabling randomized controlled trials (RCTs).
- Sector
- Healthcare
- HQ
- Manchester, United Kingdom
- Founded
- 2016
- Employees
- 60
- Website
- nweh.co.uk/
- Ownership
- Privately Held (backing)
NorthWest EHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NorthWest EHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NorthWest EHealth in its N-PORT filings yet. We sweep new filings monthly.